A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This article provides a protocol for the echocardiographic assessment of right ventricular size and pulmonary hypertension in mice. Applications include phenotype determination and serial assessment in transgenic and toxin-induced mouse models of cardiomyopathy and pulmonary vascular disease.
Transgenic and toxic models of pulmonary arterial hypertension (PAH) are widely used to study the pathophysiology of PAH and to investigate potential therapies. Given the expense and time involved in creating animal models of disease, it is critical that researchers have tools to accurately assess phenotypic expression of disease. Right ventricular dysfunction is the major manifestation of pulmonary hypertension. Echocardiography is the mainstay of the noninvasive assessment of right ventricular function in rodent models and has the advantage of clear translation to humans in whom the same tool is used. Published echocardiography protocols in murine models of PAH are lacking.
In this article, we describe a protocol for assessing RV and pulmonary vascular function in a mouse model of PAH with a dominant negative BMPRII mutation; however, this protocol is applicable to any diseases affecting the pulmonary vasculature or right heart. We provide a detailed description of animal preparation, image acquisition and hemodynamic calculation of stroke volume, cardiac output and an estimate of pulmonary artery pressure.
Elevated pulmonary pressure and right ventricular (RV) dysfunction are the hallmarks of pulmonary vascular disease in animal models and human patients with pulmonary arterial hypertension (PAH). Transgenic and toxic (e.g. monocrotaline or hypoxia) models of PAH are widely used to study the pathophysiology of PAH and to investigate potential therapies. Given the expense and time involved in creating animal models of disease, it is critical that researchers have tools to accurately assess phenotypic expression of disease.
Echocardiography is the mainstay of the noninvasive assessment of ventricular function in rodent models1,2. Echocardiography has the advantage of clear translation to humans in whom the same tool is used. In addition, some genetic models exhibit incomplete penetrance3; the ability to noninvasively identify affected animals saves valuable time and resources. Noninvasive assessment of disease severity without sacrificing an animal also allows researchers to serially study the effects of investigative therapies. This is especially important given the rapidity with which translational therapies can progress to human trials4,5.
In humans, echocardiographic assessment of RV size and pulmonary hypertension is particularly challenging due to the retrosternal position and irregular shape of the RV6. Rodent models have the added challenges of small size and extremely rapid heart rates (300-700 beat/min). Recent advances including higher frame rates and smaller transducers have improved image quality and even allowed conscious imaging in some experimental protocols, though most rodent imaging is done under anesthesia7,8. Excellent experimental protocols of echocardiography in rat models of PAH have been described and validated against both MRI and invasive hemodynamics1,9. However, published echocardiography protocols in murine models of PAH are lacking.
In this article, we describe a protocol for assessing RV and pulmonary vascular function in a mouse model of PAH with a dominant negative BMPRII mutation and a model of isolated RV afterload after pulmonary artery banding; however, this protocol is applicable to any diseases affecting the pulmonary vasculature or right heart. We will describe animal preparation and detailed assessment of RV size and function as well as main pulmonary artery (PA) size. We also demonstrate the techniques and calculations needed to estimate stroke volume and cardiac output. Technical limitations preclude accurate Doppler estimates of pulmonary pressure, but we have applied a well-validated human surrogate, pulmonary artery acceleration time, to estimate PA pressure.
Access restricted. Please log in or start a trial to view this content.
1. Equipment Preparation
2. Mouse Preparation Including Anesthesia, Hair Removal, and Positioning
3. Acquisition of Images: Imaging in Parasternal Long Axis View
4. Acquisition of Images: Imaging in Parasternal Short Axis View
Access restricted. Please log in or start a trial to view this content.
The principal goals of this protocol are to quantify RV size and function, and to understand the degree to which the pulmonary vasculature is diseased. Appropriate preparation of both the mouse and echocardiography equipment is essential to obtaining accurate and reproducible results. Mice should have their chest depilated and limbs secured to the imaging platform with tape. Anesthesia, in this case isoflurane, is administered via nose cone. The transducer should be checked for defects, particularly air bubbles, which ca...
Access restricted. Please log in or start a trial to view this content.
Mouse models of disease, either transgenic or toxin-related, require phenotypic validation that the model actually recapitulates the human disease it is intended to emulate. This validation can often be accomplished by the presence or absence of a particular feature, for example development of a tumor. However, models that result in hemodynamic abnormalities such as aortic constriction models of left ventricular hypertrophy or our transgenic model of PAH are more difficult to validate. These models require either termina...
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
Name | Company | Catalog Number | Comments |
Vevo 770 High Resolution Micro-Ultrasound System | Visualsonics Inc. | get more info at www.visualsonics.com/products | |
RMV (Real-Time MicroVisualization) 704B 40 mH Scanhead w/ Encapsulated Transducer | Visualsonics Inc. | get more info at www.visualsonics.com/products | |
Vevo Integrated Rail System including the Physioogical Monitoring System | Visualsonics Inc. | get more info at www.visualsonics.com/products | |
Computer Monitor set up for use with the Vevo770 | DELL or other General Supplier | ||
Computer Mouse set up for use with the Vevo770 | General Supplier | ||
Vevo770 Cardiac Package Software | Visualsonics Inc. | get more info at www.visualsonics.com/products | |
VetEquip Portable Tabletop Anesthesia Machine with an Isoflurane Vaporizer | VetEquip | get more info at vetequip.com | |
Activated Charcoal Waste Gas Containers | VetEquip/Vaporguard | 931401 | get more info at vetequip.com |
Puralube Eye Ointment | Henry Schein | get more info at henryschein.com | |
Ecogel 100 Ultrasound Gel | EcoMed Pharmaceuticals | 30GB | get more info at ecomed.com |
3M Transpore Tape | Fisher Scientific | 1527-0 | get more info at fishersci.com |
Small Flathead Screwdriver | General Supplier | ||
Sterile H2O | DDI H2O from faucet and then autoclave | ||
6 in Cotton Tipped Applicators | Fisher Scientific | get more info at fishersci.com | |
Nair (depilatory cream) | General Supplier | ||
2 in x 2 in Gauze Sponges | Fisher Scientific | get more info at fishersci.com |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved